Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AD/PD 2026 | The ongoing role of neuropathology to study neurodegenerative diseases in the biomarker era

Lea Grinberg, MD, PhD, Mayo Clinic, Jacksonville, FL, discusses the continued significance of neuropathology in understanding neurodegenerative diseases, noting its unique ability to provide high-resolution insights into brain tissue. She highlights that advances in methodology have revitalized the field, enabling researchers to observe previously unseen details and help guide the development of predictive biomarkers. This interview took place at the AD/PD™ 2026 International Conference on Alzheimer’s and Parkinson’s Diseases in Copenhagen, Denmark.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Neuropathology is the kind of science in which we look at tissue from the brain, usually donated by people who had a disease or didn’t have but wanted to have their brain studied so we can understand better aging and neurodegenerative diseases. And because we have direct access to tissue, we can see under the microscope exactly what is going on there with a kind of resolution that no other way or discipline can give us...

Neuropathology is the kind of science in which we look at tissue from the brain, usually donated by people who had a disease or didn’t have but wanted to have their brain studied so we can understand better aging and neurodegenerative diseases. And because we have direct access to tissue, we can see under the microscope exactly what is going on there with a kind of resolution that no other way or discipline can give us. So neuropathology is something that exists for more than 100 years, but it came to a point that people felt that we learned everything we had to learn from what we can see under the microscope and we should move on to more modern techniques. And this was true, this was fair. But in the past years, with so many advances in methodology for everything, these methods also came to be used in human tissue. So now we can see under the microscope and using other techniques things that we couldn’t see before. And because the resolution is so much better, it’s guiding us and teaching us what we should be looking at in living patients to predict dementia or maybe to check if our treatments work better. And some of these findings that we are having were not on the radar, so I’m super excited about how it’s helping really to shape the way we are seeing dementia now and in the future.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...

Disclosures

Advisory Board: UCB.